Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Diabetes Res ; 2019: 3915253, 2019.
Article in English | MEDLINE | ID: mdl-31886278

ABSTRACT

Gestational diabetes mellitus (GDM) is a complication that increasingly affects pregnant women. Due to the risk of adverse outcomes in the mother as well as in the fetus which is caused by GDM, appropriate diagnosis and treatment is very essential. Nevertheless, it is important to find new, effective ways of prevention of GDM to avoid side effects. A promising example of such an action may be supplementation of myoinositol. As shown in studies, myoinositol may reduce the risk of developing gestational diabetes mellitus by improving insulin sensitivity.


Subject(s)
Blood Glucose/drug effects , Diabetes, Gestational/prevention & control , Dietary Supplements , Hypoglycemic Agents/therapeutic use , Inositol/therapeutic use , Animals , Biomarkers/blood , Blood Glucose/metabolism , Diabetes, Gestational/blood , Diabetes, Gestational/diagnosis , Diabetes, Gestational/physiopathology , Dietary Supplements/adverse effects , Female , Humans , Hypoglycemic Agents/adverse effects , Inositol/adverse effects , Insulin Resistance , Pregnancy , Risk Assessment , Risk Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL